Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2315.HK
2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2256.HK
Abbisko Cayman Limited 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 1672.HK
Ascletis Pharma Inc. 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2142.HK
HBM Holdings Limited 1302.HK
LifeTech Scientific Corporation 2192.HK
Medlive Technology Co., Ltd. 1858.HK
Beijing Chunlizhengda Medical Instruments Co., Ltd.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2256.HK
Abbisko Cayman Limited 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 1672.HK
Ascletis Pharma Inc. 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2142.HK
HBM Holdings Limited 1302.HK
LifeTech Scientific Corporation 2192.HK
Medlive Technology Co., Ltd. 1858.HK
Beijing Chunlizhengda Medical Instruments Co., Ltd.
Performance
| Periode | 2315.HK | 2256.HK | 0775.HK | 1672.HK | 2171.HK | 2616.HK | 2142.HK | 1302.HK | 2192.HK | 1858.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 101.19 % | 127.19 % | 18.42 % | 88.66 % | 35.09 % | 174.90 % | 78.13 % | 44.68 % | 0.87 % | 81.35 % |
| YTD | 186.02 % | 252.38 % | 119.51 % | 187.65 % | 83.48 % | 181.63 % | 545.96 % | 48.91 % | 19.46 % | 92.12 % |
| 1Y | 216.96 % | 300.52 % | 87.50 % | 590.37 % | 329.18 % | 283.33 % | 907.09 % | 48.91 % | 31.52 % | 100.89 % |
| 3Y | -8.69 % | 432.19 % | 45.16 % | 305.22 % | 29.79 % | 93.28 % | 931.45 % | -25.82 % | 69.34 % | 18.28 % |
| 5Y | -8.69 % | 25.32 % | 2.27 % | 205.57 % | -42.63 % | -43.44 % | 16.06 % | -0.49 % | -62.58 % | -57.96 % |
| 10Y | -8.69 % | 25.32 % | 21.62 % | -33.43 % | -42.63 % | -46.35 % | 16.06 % | 85.45 % | -62.58 % | 511.97 % |
| From the beginning | -8.69 % | 25.32 % | -69.05 % | -33.43 % | -42.63 % | -46.35 % | 16.06 % | 716.00 % | -62.58 % | 454.20 % |